Skip to content
Disclosery

MRA Advisory Group: IBD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MRA Advisory Group on IBD, newest first. How the timeline and the estimate are built.

MRA Advisory Group held 14,923 IBD shares at 2026-09-30 per its 13F-HR filed 2026-10-07.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 14,923 shares
    Change vs previous 13F +196 shares

    0.13% of the 13F portfolio, value $343,227.

    13F-HR 0001841816-26-000007 filed by MRA Advisory Group
    Accepted , ingested

  2. period ended2026-06-30
    13F 14,727 shares
    Change vs previous 13F +3,489 shares

    0.13% of the 13F portfolio, value $350,057.

    13F-HR 0001841816-26-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 11,238 shares
    Change vs previous 13F not available

    0.11% of the 13F portfolio, value $268,113.

    13F-HR 0001841816-26-000002 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).